fda 503a bulks list category 2 bpc-157 When will the reclassify to 1? Odds & Predictions FDA Removes 12 Peptides from

reduced cardiac damage following myocardial stress Collateral pathway activation: BPC-157 demonstrated upgrading of minor vessels to compensate for major vessel occlusion Central Nervous System Research Neuroprotection Studies Research in traumatic brain injury and stroke models demonstrated neuroprotective effects from both peptides[14,15]: BPC-157 : Reduced lesion volumes in cortical injury

Possible Allergic Reactions: Rare, but always check ingredients

- Sharon H.

Thorax 57(10):875879 Hamid Q, Tulic MK, Liu MC, Moqbel R (2003) Inflammatory cells in asthma: mechanisms and implications for therapy

Topical formulations (0.05%-1% concentration creams/serums) are used daily with no defined cycle limit